These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38145420)

  • 41. Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability.
    Dangre P; Gilhotra R; Dhole S
    Drug Deliv Transl Res; 2016 Oct; 6(5):610-21. PubMed ID: 27465619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies.
    Shao B; Cui C; Ji H; Tang J; Wang Z; Liu H; Qin M; Li X; Wu L
    Drug Deliv; 2015; 22(6):740-7. PubMed ID: 24670090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved oral bioavailability of febuxostat by liquid self-micro emulsifying drug delivery system in capsule shells.
    Londhe V; Bakshi P
    Ann Pharm Fr; 2023 Sep; 81(5):833-842. PubMed ID: 37178907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats.
    Kim JY; Ku YS
    Int J Pharm; 2000 Jan; 194(1):81-9. PubMed ID: 10601687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement.
    Duc Hanh N; Mitrevej A; Sathirakul K; Peungvicha P; Sinchaipanid N
    Drug Dev Ind Pharm; 2015 Feb; 41(2):207-17. PubMed ID: 24237327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems.
    Dong-Qin Q; Gui-Xia X; Xiang-Gen W
    PDA J Pharm Sci Technol; 2007; 61(1):37-43. PubMed ID: 17390702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced Intestinal Permeability of Cefixime by Self-Emulsifying Drug Delivery System: In-Vitro and Ex-Vivo Characterization.
    Mahmood A; Khan L; Ijaz M; Nazir I; Naseem M; Tahir MA; Aamir MN; Rehman MU; Asim MH
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The preparation and relative bioavailability of an artemisin in self-emulsifying drug delivery system.
    Gao S; Chen J; Peng W; Yang Y; Yang Y; Hua L; Guo Y; Wang Y; Zhang X
    Drug Deliv; 2023 Dec; 30(1):2168794. PubMed ID: 36708154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.
    Kommuru TR; Gurley B; Khan MA; Reddy IK
    Int J Pharm; 2001 Jan; 212(2):233-46. PubMed ID: 11165081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235).
    Visetvichaporn V; Kim KH; Jung K; Cho YS; Kim DD
    Int J Pharm; 2020 Jan; 573():118772. PubMed ID: 31765770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A.
    Qi J; Zhuang J; Wu W; Lu Y; Song Y; Zhang Z; Jia J; Ping Q
    Int J Nanomedicine; 2011; 6():985-91. PubMed ID: 21720510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
    Tran TH; Guo Y; Song D; Bruno RS; Lu X
    J Pharm Sci; 2014 Mar; 103(3):840-52. PubMed ID: 24464737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-emulsifying drug delivery systems: A versatile approach to enhance the oral delivery of BCS class III drug via hydrophobic ion pairing.
    Asad M; Rasul A; Abbas G; Shah MA; Nazir I
    PLoS One; 2023; 18(6):e0286668. PubMed ID: 37294790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formulation and In Vitro Evaluation of Self Microemulsifying Drug Delivery System Containing Atorvastatin Calcium.
    Diril M; Türkyılmaz GY; Karasulu HY
    Curr Drug Deliv; 2019; 16(8):768-779. PubMed ID: 31429689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
    Jain S; Jain AK; Pohekar M; Thanki K
    Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-hyperuricemic property of 6-shogaol via self-micro emulsifying drug delivery system in model rats: formulation design,
    Yang Q; Wang Q; Feng Y; Wei Q; Sun C; Firempong CK; Adu-Frimpong M; Li R; Bao R; Toreniyazov E; Ji H; Yu J; Xu X
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1265-1276. PubMed ID: 30990749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
    Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
    Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol.
    Kazi M; Alqahtani A; Alharbi M; Ahmad A; Hussain MD; Alothaid H; Aldughaim MS
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
    Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
    Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation.
    Shaker DS; Ishak RAH; Elhuoni MA; Ghoneim AM
    Int J Pharm; 2020 Mar; 578():119073. PubMed ID: 31982556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.